Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus

Journal of Neurochemistry

Volumn 77, Issue 3, 2001, Pages 957-960

  Derkinderen, Pascal ^a,b   Ledent, Catherine ^c   Parmentier, Marc ^c   Girault, Jean Antoine ^a,d  

^a INSTITUT DU FER À MOULIN   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d l'alimentation et l'Environnement   (France)

Author keywords

2 arachidonoyl glycerol; Anandamide; c Jun N terminal kinase; Lysophosphatidic acid

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; LYSOPHOSPHATIDIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; RIMONABANT; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVATION; MALE; MOUSE; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALIA;

EID: 0035019372     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00333.x     Document Type: Article

References (31)

1. Bohme G. A., Laville M., Ledent C., Parmentier M. and Imperato A. (2000) Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. Neuroscience 95, 5-7.
2. Bolshakov V. Y., Carboni L., Cobb M. H., Siegelbaum S. A. and Belardetti F. (2000) Dual MAP kinase pathways mediate opposing forms of long-term plasticity at CA3-CA1 synapses. Nat. Neurosci. 3, 1107-1112.
3. Chan G. C.-K., Hinds T. R., Impey S. and Storm D. R. (1998) Hippocampal neurotoxicity of Δ9-tetrahydrocannabinol. J. Neurosci. 18, 5322-5332.
4. Derkinderen P., Toutant M., Burgaya F., Le Bert M., Siciliano J. C., de Franciscis V., Gelman M. and Girault J. A. (1996) Regulation of a neuronal form of focal adhesion kinase by anandamide. Science 273, 1719-1723.
5. Derkinderen P., Siciliano J., Toutant M. and Girault J.-A. (1998) Differential regulation of FAK and PYK2/Cakβ in rat hippocampal slices. Effects of LPA, carbachol, depolarization and hyperosmolarity. Eur. J. Neurosci. 10, 1667-1675.
6. Derkinderen P., Enslen H. and Girault J.-A. (1999) The ERK/MAP-kinases cascade in the nervous system. Neuroreport 10, R24-R34.
7. Di Marzo V., Melck D., Bisogno T. and De Petrocellis L. (1998) Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 21, 521-528.
8. Felder C. C. and Glass M. (1998) Cannabinoid receptors and their endogenous agonists. Annu. Rev. Pharmacol. Toxicol. 38, 179-200.
9. Galve-Roperh I., Sanchez C., Cortés M. L., Gomez del Pulgar T., Izquierdo M. and Guzman M. (2000) Anti-tumoral action of cannabinoids: involvement of sustained ceramide-accumulation and extracellular signal-regulated kinase activation. Nat. Med. 6, 313-319.
10. Gomez del Pulgar T., Velasco G. and Guzman M. (2000) The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt. Biochem. J. 347, 369-373.
11. Hanke J. H., Gardner J. P., Dow R. L., Changelian P. S., Brissette W. H., Weringer E. J., Pollok B. A. and Connelly P. A. (1996) Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. J. Biol. Chem. 271, 695-701.
12. Hecht J. H., Weiner J. A., Post S. R. and Chun J. (1996) Ventricular Zone Gene-1 (vzg-1) encodes a lysophosphatidic acid receptor in neurogenic regions of the developing cerebral cortex. J. Cell Biol. 135, 1071-1083.
13. Howlett A. C. and Mukhopadhyay S. (2000) Cellular signal transduction by anandamide and 2-arachidonylglycerol. Chem. Phys. Lipids 1, 53-70.
14. Ledent C., Valverde O., Cossu G., Petitet F., Aubert J., Beslot F., Bohme G., Imperato A., Pedrazzini T., Roques B., Vassart G., Fratta W. and Parmentier M. (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283, 401-404.
15. Liu J., Gao B., Mirshahi F., Sanyal A., Khanolkar A. D., Makryiyannis A. and Kunos G. (2000) Functional CB1 cannabinoid receptors in human vascular endothelial cells. Biochem. J. 346, 835-840.
16. Melck D., Rueda D., Galve-Roperh I., De Petrocellis L., Guzman M. and Di Marzo V. (1999) Involvement of the cAMP/protein kinase A pathway and of mitogen activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells. FEBS Lett. 463, 235-240.
17. Misner D. L. and Sullivan J. M. (1999) Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J. Neurosci. 19, 6795-6805.
18. q/11-induced activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase. J. Biol. Chem. 273, 22892-22898.
19. Nagayama T., Sinor A. D., Simon R. P., Chen J., Graham S. H., Jin K. and Greenberg D. A. (1999) Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J. Neurosci. 19, 2987-2995.
20. Reibaud M., Obinu M. C., Ledent C., Parmentier M., Bohme G. A. and Imperato A. (1999) Enhancement of memory in cannabinoid CB1 receptor knock-out mice. Eur J. Pharmacol. 379, R1-R2.
21. ReiSeries C. O. A., Lanz T., Hofmann F., Hofer G., Rupprecht H. D. and Goppelt-Struebe M. (1998) Lysophosphatidic acid-mediated signal-transduction pathways involved in the induction of the early-response genes prostaglandin G/H synthase-2 and egr-1: a critical role for the mitogen-activated protein kinase p38 and for Rho proteins. Biochem. J. 330, 1107-1114.
22. Rinaldi-Carmona M., Barth F., Héaulme M., Shir D., Calandra B., Congy C., Martinez S., Maruani J., Néliat G., Caput D., Ferrara P., Soubrié P., Brelière J. C. and Le Fur G. (1994) SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350, 240-244.
23. Rueda D., Galve-Roperth I., Haro A. and Guzman M. (2000) The CB (1) cannabinoid receptor is coupled to the activation of c-June N-terminal kinase. Mol. Pharmacol. 58, 814-820.
24. Saleshando G. and O'Connor J. J. (2000) SB203580, the p38 mitogen-activated protein kinase inhibitor blocks the inhibitory effect of beta-amyloid on long-term potentiation in the rat hippocampus. Neurosci. Lett. 288, 119-122.
25. Schaeffer H. J. and Weber M. J. (1999) Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell Biol. 19, 2435-2444.
26. Siciliano J. C., Gelman M. and Girault J. A. (1994) Depolarization and neurotransmitters increase neuronal protein tyrosine phosphorylation. J. Neurochem. 62, 950-959.
27. Stella N., Schweitzer P. and Piomelli D. (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388, 773-778.
28. Tsou K., Brown S., Sanudo-Pena M. C., Mackie K. and Walker J. M. (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83, 393-411.
29. Yamboliev I. A., Wiesmann K. M., Singer C. A., Hedges J. C. and Gerthoffer W. T. (2000) Phosphatidylinositol 3-kinases regulate ERK and p38 MAP kinases in canine colonic smooth muscle. Am. J. Physiol. Cell Physiol. 279, C352-C360.
30. Yang D. D., Kuan C.-Y., Whithmarsh A. J., Rincon M., Zheng T. S., Davis R. J., Rakic P. and Flavell R. A. (1997) Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389, 865-869.
31. Yu H., Li X., Marchetto G. S., Dy R., Hunter D., Calvo B., Dawson T. L., Wilm M., Anderegg R. J., Graves L. M. and Earp S. H. (1996) Activation of a novel calcium-dependent protein-tyrosine kinase. J. Biol. Chem. 271, 29993-29998.